MMRD ENDOMETRIAL CANCER OF STAGE I~II

Clinical trials for MMRD ENDOMETRIAL CANCER OF STAGE I~II explained in plain language.

Never miss a new study

Get alerted when new MMRD ENDOMETRIAL CANCER OF STAGE I~II trials appear

Sign up with your email to follow new studies for MMRD ENDOMETRIAL CANCER OF STAGE I~II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Can an immunotherapy drug replace surgery for some endometrial cancers?

⭐️ CURE ⭐️ Not yet recruiting

This phase 2 trial is testing whether the immunotherapy drug sintilimab can eliminate early-stage (I-II) MSI-H/dMMR endometrial cancer without the need for surgery. About 48 participants will receive sintilimab alone every three weeks. The goal is to see if the drug can produce a…

Matched conditions: MMRD ENDOMETRIAL CANCER OF STAGE I~II

Phase: PHASE2 • Sponsor: Wang Jianliu • Aim: ⭐️ CURE ⭐️

Last updated Jul 30, 2026 00:00 UTC

MMRD ENDOMETRIAL CANCER OF STAGE I~II

Get alerted when new MMRD ENDOMETRIAL CANCER OF STAGE I~II trials appear

Can an immunotherapy drug replace surgery for some endometrial cancers?